Dr. Lindsey Sloan, MD, PhD

Dr. Sloan practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Sloan's NPI, 1073991840, was assigned on May 13, 2015. Dr. Sloan graduated from Lewis Katz School of Medicine in 2015. Dr. Sloan's Minnesota license number on file is 67095.

Dr. Sloan's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Sloan's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Sloan is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Sloan to 9 more medical groups, 6 group practices and clinics, 1 dialysis center and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sloan practices, 10 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Sloan's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Sloan is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Sloan's licenses on file in 2 states: Minnesota and Pennsylvania.

Dmand AI lists brain tumor radiation, lung cancer radiation and uterine cancer radiation among the conditions Dr. Sloan treats.

CMS data shows 266 Medicare services from Dr. Sloan across 5 procedure codes in 2024, for 71 Medicare patients. Medicare paid $14,268 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 71 Medicare patients who saw Dr. Sloan in 2024. The largest group is 65 to 74, with 36 patients. 65% of them have high blood pressure, and 62% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sloan's median patient age at 61, with 55% women.

In 2024, Dr. Sloan wrote 18 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $171 in total drug cost. In 2018, CMS named 32 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Sloan for performance year 2024, reported as part of a group. Dr. Sloan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sloan as offering telehealth.

Dmand AI links 16 papers to Dr. Sloan, published from 2018 to 2025. 2018 was the busiest year, with 3. The most frequent topics are Glioblastoma, Brain Neoplasms and Tumor Microenvironment. Dr. Sloan has published most often in Front Immunol. Dr. Sloan's most frequent co-authors are Lawrence Kleinberg, MD, Michael Lim, MD and Elizabeth Catherine Neil, MD.

CMS Open Payments shows 10 general payments to Dr. Sloan from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 51% of the total. GT Medical Technologies, Inc paid the most, $2,106.

Dr. Sloan graduated from Lewis Katz School of Medicine in 2015.

Dr. Sloan is in network with 13 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.